More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone
Portfolio Pulse from Chris Katje
COVID-19 vaccine boosters from Pfizer Inc (PFE), Moderna Inc (MRNA), and BioNTech SE - ADR (BNTX) have been approved by the U.S. FDA. Novavax Inc (NVAX) has a vaccine booster awaiting approval. A new survey shows that over half of U.S. registered voters plan to get a COVID-19 booster vaccine this year. The approval of these boosters comes as hospitalizations related to COVID-19 have increased in recent months.
September 15, 2023 | 8:19 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Novavax's COVID-19 booster is awaiting FDA approval. If approved, this could increase demand for the company's vaccine.
Novavax's COVID-19 booster is still awaiting FDA approval. If approved, this could lead to increased demand for the vaccine, potentially boosting the company's revenues.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
BioNTech's COVID-19 booster has been approved by the FDA, which could increase demand for the company's vaccine.
The FDA's approval of BioNTech's COVID-19 booster could lead to increased demand for the vaccine, potentially boosting the company's revenues.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Moderna's COVID-19 booster has been approved by the FDA, which could increase demand for the company's vaccine.
The FDA's approval of Moderna's COVID-19 booster could lead to increased demand for the vaccine, potentially boosting the company's revenues.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Pfizer's COVID-19 booster has been approved by the FDA, which could increase demand for the company's vaccine.
The FDA's approval of Pfizer's COVID-19 booster could lead to increased demand for the vaccine, potentially boosting the company's revenues.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100